Drug Regulator Latest Report on Paracetamol and Pan D Quality Issues
The Central Drugs Standard Control Organisation (CDSCO) has released its latest report, revealing that samples of over 50 drugs, including paracetamol and Pan D, have failed quality testing. This report underscores the critical need for maintaining drug quality and ensuring public safety.
Key Findings from CDSCO Report
- More than 50 drugs listed as not of standard quality
- Paracetamol and Pan D among those that failed testing
- Importance of CDSCO quality test highlighted
Implications for Public Health
As the drug regulator, CDSCO’s findings raise concerns regarding public health and safety. Patients relying on these medications deserve assurance regarding their quality and efficacy. Regular quality testing must be prioritized to prevent potential health risks.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.